Combined TCR Repertoire Profiles and Blood Cell Phenotypes Predict Melanoma Patient Response to Personalized Neoantigen Therapy plus Anti-PD-1

被引:42
作者
Poran, Asaf [1 ]
Scherer, Julian [1 ]
Bushway, Meghan E. [1 ]
Besada, Rana [1 ]
Balogh, Kristen N. [1 ]
Wanamaker, Amy [1 ]
Williams, Reid G. [1 ]
Prabhakara, Jasmina [1 ]
Ott, Patrick A. [2 ,3 ]
Hu-Lieskovan, Siwen [4 ]
Khondker, Zakaria S. [1 ]
Gaynor, Richard B. [1 ]
Rooney, Michael S. [1 ]
Srinivasan, Lakshmi [1 ]
机构
[1] Neon Therapeut BioNTech US, Cambridge, MA 02139 USA
[2] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA
关键词
CANCER; DIVERSITY; REVEALS;
D O I
10.1016/j.xcrm.2020.100141
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
T cells use highly diverse receptors (TCRs) to identify tumor cells presenting neoantigens arising from genetic mutations and establish anti-tumor activity. Immunotherapy harnessing neoantigen-specific T cells to target tumors has emerged as a promising clinical approach. To assess whether a comprehensive peripheral mononuclear blood cell analysis predicts responses to a personalized neoantigen cancer vaccine combined with anti-PD-1 therapy, we characterize the TCR repertoires and T and B cell frequencies in 21 patients with metastatic melanoma who received this regimen. TCR-alpha/beta-chain sequencing reveals that prolonged progression-free survival (PFS) is strongly associated with increased clonal baseline TCR repertoires and longitudinal repertoire stability. Furthermore, the frequencies of antigen-experienced T and B cells in the peripheral blood correlate with repertoire characteristics. Analysis of these baseline immune features enables prediction of PFS following treatment. This method offers a pragmatic clinical approach to assess patients' immune state and to direct therapeutic decision making.
引用
收藏
页数:14
相关论文
共 44 条
[1]   Building and Optimizing a Virus-specific T Cell Receptor Library for Targeted Immunotherapy in Viral Infections [J].
Banu, Nasirah ;
Chia, Adeline ;
Ho, Zi Zong ;
Garcia, Alfonso Tan ;
Paravasivam, Komathi ;
Grotenbreg, Gijsbert M. ;
Bertoletti, Antonio ;
Gehring, Adam J. .
SCIENTIFIC REPORTS, 2014, 4
[2]   Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis [J].
Benedict Sacdalan, Danielle ;
Anne Lucero, Josephine ;
Lee Sacdalan, Dennis .
ONCOTARGETS AND THERAPY, 2018, 11 :955-965
[3]   MiXCR: software for comprehensive adaptive immunity profiling [J].
Bolotin, Dmitriy A. ;
Poslavsky, Stanislav ;
Mitrophanov, Igor ;
Shugay, Mikhail ;
Mamedov, Ilgar Z. ;
Putintseva, Ekaterina V. ;
Chudakov, Dmitriy M. .
NATURE METHODS, 2015, 12 (05) :380-381
[4]   Age-Related Decrease in TCR Repertoire Diversity Measured with Deep and Normalized Sequence Profiling [J].
Britanova, Olga V. ;
Putintseva, Ekaterina V. ;
Shugay, Mikhail ;
Merzlyak, Ekaterina M. ;
Turchaninova, Maria A. ;
Staroverov, Dmitriy B. ;
Bolotin, Dmitriy A. ;
Lukyanov, Sergey ;
Bogdanova, Ekaterina A. ;
Mamedov, Ilgar Z. ;
Lebedev, Yuriy B. ;
Chudakov, Dmitriy M. .
JOURNAL OF IMMUNOLOGY, 2014, 192 (06) :2689-2698
[5]   Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond [J].
Cohen, Cyrille J. ;
Li, Yong F. ;
El-Gamil, Mona ;
Robbins, Paul F. ;
Rosenberg, Steven A. ;
Morgan, Richard A. .
CANCER RESEARCH, 2007, 67 (08) :3898-3903
[6]  
Coley W B, 1891, Ann Surg, V14, P199, DOI 10.1097/00000658-189112000-00015
[7]  
Drost HG, 2018, J. Open Source Softw, V3, P765, DOI DOI 10.21105/JOSS.00765
[8]  
Ehrlich P, 1909, BER DTSCH CHEM GES, V42, P17, DOI 10.1002/cber.19090420105
[9]   Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma [J].
Fairfax, Benjamin P. ;
Taylor, Chelsea A. ;
Watson, Robert A. ;
Nassiri, Isar ;
Danielli, Sara ;
Fang, Hai ;
Mahe, Elise A. ;
Cooper, Rosalin ;
Woodcock, Victoria ;
Traill, Zoe ;
Al-Mossawi, M. Hussein ;
Knight, Julian C. ;
Klenerman, Paul ;
Payne, Miranda ;
Middleton, Mark R. .
NATURE MEDICINE, 2020, 26 (02) :193-+
[10]  
Finn OJ, 2012, ANN ONCOL, V23, P6, DOI 10.1093/annonc/mds256